IN2014CN03364A - - Google Patents

Download PDF

Info

Publication number
IN2014CN03364A
IN2014CN03364A IN3364CHN2014A IN2014CN03364A IN 2014CN03364 A IN2014CN03364 A IN 2014CN03364A IN 3364CHN2014 A IN3364CHN2014 A IN 3364CHN2014A IN 2014CN03364 A IN2014CN03364 A IN 2014CN03364A
Authority
IN
India
Prior art keywords
nanoparticles
cell epitopes
oligomerization domains
peptide
norovirus
Prior art date
Application number
Other languages
English (en)
Inventor
Peter Burkhard
Caroline Kulangara
Original Assignee
Alpha O Peptides Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha O Peptides Ag filed Critical Alpha O Peptides Ag
Publication of IN2014CN03364A publication Critical patent/IN2014CN03364A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
IN3364CHN2014 2011-10-12 2012-10-05 IN2014CN03364A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11184906 2011-10-12
PCT/EP2012/069684 WO2013053642A1 (en) 2011-10-12 2012-10-05 Self-assembling peptide nanoparticles as vaccines against infection with norovirus

Publications (1)

Publication Number Publication Date
IN2014CN03364A true IN2014CN03364A (de) 2015-09-04

Family

ID=47010584

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3364CHN2014 IN2014CN03364A (de) 2011-10-12 2012-10-05

Country Status (9)

Country Link
US (1) US20140242104A1 (de)
EP (1) EP2766386A1 (de)
JP (1) JP2014530224A (de)
CN (1) CN104136454A (de)
AU (1) AU2012323189A1 (de)
CA (1) CA2851917A1 (de)
IN (1) IN2014CN03364A (de)
RU (1) RU2014106936A (de)
WO (1) WO2013053642A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106021974B (zh) * 2016-05-19 2019-05-03 中牧智合（北京）生物技术有限公司 对t细胞表位进行优化的方法及由此制备的肽文库的组合物
EA201991918A1 (ru) * 2017-03-23 2020-05-15 Альфа-О Пептидс Аг Самосборные белковые наночастицы со встроенными белками с шестиспиральным пучком
AU2019285048B2 (en) * 2018-06-13 2023-06-08 The Scripps Research Institute Nanoparticle vaccines with novel structural components
WO2020220846A1 (zh) * 2019-04-29 2020-11-05 中国人民解放军军事科学院军事医学研究院 一种可自组装为蛋白纳米颗粒的融合蛋白及其应用
WO2022106860A1 (en) * 2020-11-20 2022-05-27 Pécsi Tudományegyetem Recombinant peptides for use in therapy
US20240316181A1 (en) * 2021-01-07 2024-09-26 Tokyo Institute Of Technology Conjugated protein monomer carrying peptide derived from pathogenic microorganism compatible with mhc molecule, aggregate of said monomers, component vaccine containing said aggregate as active ingredient, and method for acquiring information on secretion of physiologically active substance after immunization
CN113354716B (zh) * 2021-08-11 2021-11-02 北京溯本源和生物科技有限公司 一种鼠诺如病毒重组抗原、单克隆抗体和病毒检测试纸条

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2581394B1 (fr) 1985-05-02 1988-08-05 Grp Genie Genetique Particules ayant les proprietes immunogenes de l'antigene hbs et portant un site antigenique etranger aux epitopes portes par l'antigene hbs, vecteurs et cellules animales pour la production de telles particules et compositions contenant de telles particules pour la production de vaccins mixtes
JP3926839B2 (ja) 1993-09-14 2007-06-06 エピミューン，インコーポレイティド 万能ｄｒ−結合性ペプチドを用いる免疫応答の改変
JP4085231B2 (ja) 2000-02-28 2008-05-14 株式会社ビークル タンパク質中空ナノ粒子とそれを用いた物質運搬体、ならびに細胞への物質導入方法
US8575110B2 (en) 2003-02-17 2013-11-05 Alpha-O Peptides G Peptidic nanoparticles as drug delivery and antigen display systems
AU2008302276B2 (en) * 2006-09-29 2013-10-10 Takeda Vaccines, Inc. Method of conferring a protective immune response to norovirus
RU2540871C2 (ru) * 2008-02-01 2015-02-10 Альфа-О Пептидес Аг Самоорганизующиеся пептидные наночастицы, полезные в качестве вакцин
DE602008004898D1 (de) * 2008-06-27 2011-03-24 Theranor Sprl Pharmazeutische Zusammensetzungen von Antikörpern von Viruserkrankungen

Also Published As

Publication number Publication date
AU2012323189A1 (en) 2014-03-06
EP2766386A1 (de) 2014-08-20
RU2014106936A (ru) 2015-11-20
US20140242104A1 (en) 2014-08-28
CN104136454A (zh) 2014-11-05
JP2014530224A (ja) 2014-11-17
WO2013053642A1 (en) 2013-04-18
CA2851917A1 (en) 2013-04-18

Similar Documents

Publication Publication Date Title
IN2014CN03364A (de)
CY1122278T1 (el) Αντι il-36r αντισωματα
CY1121392T1 (el) Μορια δεσμευσης εναντι-αλφα συνουκλεϊνης
CY1120398T1 (el) Ανθρωποποιημενα αντισωματα που αναγνωριζουν αλφα-συνουκλεϊνη
HK1194757A1 (zh) 供人類使用的抗體、可變區與鏈特製
DK2728002T3 (da) Heterodimeriseret polypeptid
CY1118906T1 (el) Χαμηλης συγγενειας αντισωματα υποδοχεα αιματοεγκεφαλικου φραγμου και χρησεις αυτων
MX366223B (es) Proteinas vinculantes que comprenden al menos dos dominios de repeticion contra her2.
CY1119567T1 (el) Θεραπευτικα πεπτιδια
DK2940135T5 (da) Heterodimeriseret polypeptid
CY1116842T1 (el) Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου
IL243209B (en) Cyclic peptides as protein targeting agents
WO2012031250A3 (en) Compositions for labeling nerves and methods of use
CY1118885T1 (el) Συνθετικες πεπτιδογλυκανες που δεσμευουν υαλουρονικο οξυ, παρασκευη, και μεθοδοι χρησης
DK2797616T3 (da) Celle-penetrerende peptider
BR112014017749A2 (pt) Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo
WO2009109428A3 (en) Self-assembling peptide nanoparticles useful as vaccines
EP3082797A4 (de) Modifizierte therapeutika, geheftete peptidlipidkonjugate und zusammensetzungen davon
CO7010784A2 (es) Moléculas que son anticuerpos con especificidad por ox40 humano
MX355268B (es) Anticuerpos de peptido beta amiloide anti-n3pglu y usos de los mismos.
UY34608A (es) Péptidos sintéticos de tránsito al cloroplasto.
DK3252076T3 (da) Diagnostisk anvendelse af antistoffer mod ror-1-protein
JP2014518898A5 (de)
EA201390074A1 (ru) 5-хлор-4-гидрокси-1-метил-2-оксо-n-фенил-1,2-дигидрохинолин-3-карбоксамид, его соли и применения
EA201390081A1 (ru) Дейтерированный n-этил-n-фенил-1,2-дигидро-4-гидрокси-5-хлор-1-метил-2-оксохинолин-3-карбоксамид, его соли и их применение